Selank: An Anxiety Peptide Put to a Stress Test

For two weeks, researchers kept changing the conditions around a group of rats. They tilted the cages, disrupted the light cycle and made the bedding damp. Food and water were withheld at scheduled intervals. The animals could not settle into a predictable routine.

Then came a three-minute test on a raised platform shaped like a plus sign. Two arms had protective walls. Two were open. Researchers recorded how long each rat ventured into the exposed space.

The stressed rats given saline spent a median of 4.6 seconds in the open arms. Those given the peptide Selank spent 15.5 seconds there. A group given Selank together with diazepam spent 40.8 seconds in the open arms.

A median marks the middle of a group’s measurements. That last result was almost nine times the saline group's time. Understanding it requires keeping track of what the animals received, how stressed they were and what the maze could measure.

Selank contains seven amino acids, the small units that form peptides and proteins. The first four come from tuftsin, a naturally occurring peptide associated with immune activity. Researchers added three more amino acids to make the resulting molecule more stable.

That origin makes Selank an unusual candidate for anxiety research. A molecule's starting point does not limit every effect it can have after scientists change its structure. The research question is what the new sequence does when it reaches a biological system.

One possible connection involves GABA, a chemical messenger that helps restrain nerve-cell activity. A nerve cell receives many signals. Some make it more likely to fire; others make firing less likely. GABA supplies much of that inhibitory signaling in the adult brain.

GABA works through receptors, proteins that respond when a particular molecule binds to them. One receptor type, called GABA-A, contains an ion channel. Activating it changes the flow of charged particles through the cell membrane and usually makes the cell less likely to fire.

Diazepam, a benzodiazepine medicine, increases the effect of GABA at these receptors. It binds at a separate site that changes how the receptor responds to GABA. Scientists call this allosteric modulation. Think of it as changing a receptor's responsiveness to a signal it already receives.

Researchers had reasons to suspect that Selank could also influence this system. That raised a testable question: would its effects overlap with those of diazepam, and what would happen when the two were given together?

In the 2017 experiment, Anastasiya Kasian and colleagues divided 48 male rats into two main groups. Half experienced the changing stress conditions for 14 days. The other half stayed outside that stress protocol.

Within each group, six rats received saline, six received Selank, six received diazepam and six received both compounds. Selank was given through the nose; diazepam was given by mouth. Treatment continued once a day during the two weeks.

The researchers tested each rat in the maze before the treatment period and again a day after the final treatment and stress exposure. Each session lasted three minutes. The maze stood 80 centimeters above the floor.

Rats have a reason to explore unfamiliar space, but an open, elevated arm also leaves them exposed. Time spent there gives researchers an indicator of anxiety-like behavior. The walled arms offer a more sheltered option.

The measurement was seconds in a particular place. To interpret those seconds, the team also recorded movement around the maze and other exploratory actions. An animal that barely moves can spend little time in the open for reasons that overlap with, or differ from, anxiety.

Before the stress period, the groups spent roughly a minute in the open arms. Afterward, the saline group's median fell from 62.4 seconds to 4.6 seconds. The Selank group's median fell from 64.7 to 15.5 seconds.

Diazepam alone produced a final median of 26.9 seconds. The combined treatment reached 40.8 seconds, down from a starting median of 72.6 seconds.

The combined group's final open-arm time was significantly higher than the saline group's. It also spent significantly less time in the sheltered arms. Together, those results supported the authors' conclusion that the combination reduced anxiety-like behavior under this stress protocol.

The starting values help put the result in scale. The combined group's final median was still below its own starting median, although that before-and-after difference did not meet the study's threshold for statistical significance. A result can be better than the stressed control group while still falling short of its earlier value.

The paper's table marked the Selank-alone group's decline from baseline as significant. It did not mark its final open-arm time as significantly different from saline. The same distinction applied to diazepam alone on that measure. Those larger medians are worth following, but the strongest statistical comparison belonged to the combination.

This was a small animal experiment with six rats in each subgroup. It did not establish a useful treatment combination for people or test whether a lower diazepam dose could keep the benefit. The dose stayed fixed. The authors proposed dose reduction as a question for future research.

The rats outside the chronic-stress protocol supplied a second part of the story. They still received a substance every day and went through the same maze tests.

After two weeks of saline administration, their median time in the open arms fell from 48.9 seconds to 10.8 seconds. They had avoided the damp bedding, tilted cages and other scheduled stressors. Yet their behavior still changed substantially.

The authors proposed that repeated administration itself added stress. This experiment did not include an untreated group that could separate that explanation from other effects of the procedure, including the repeated maze test. The change in the saline group shows why the comparison procedure matters.

Selank alone produced the least pronounced overall deterioration in this setting, according to the authors. The observed changes in its anxiety measures did not meet their statistical threshold. Its movement measures were also relatively stable.

The combined treatment behaved differently outside the stress protocol. Its rats spent less time in the open arms after treatment, and the number of squares they crossed declined significantly. That movement result makes a broad claim about calmness without sedation difficult to draw from this experiment.

The treatment's apparent effect depended on the animals' starting conditions and the demands placed on them. Researchers need that context when they decide which result to test next.

A year before the maze paper, Anastasiya Volkova and colleagues examined how Selank affected RNA messages in the rat brain. Cells make these messages from their genes as part of producing proteins. Measuring the messages can reveal a biological response before researchers know its full effect on behavior.

The team gave rats Selank, GABA or water through the nose, then examined the frontal cortex one or three hours later. They started with a panel of 84 genes related to communication between nerve cells. Seven had too little detectable RNA for the analysis, leaving 77.

At one hour, 29 genes met the study's change threshold after Selank, while 41 did after GABA. Twenty-five appeared in both lists. The pattern of changes was strongly correlated at that early time point, giving the researchers support for a connection between Selank and GABA-related signaling.

Three hours later, the lists had changed. Selank affected 17 genes and GABA affected nine, with only four shared between the lists. The response developed over time, and the two compounds increasingly produced their own patterns.

The team pooled tissue from five rats for each treatment and time point, then repeated the laboratory measurement. Pooling let them examine the group's combined material, but it concealed variation between individual animals. This is an early clue about mechanism, with a different job from a trial that measures how a person feels or functions.

The authors proposed that Selank could alter the response of GABA receptors and also affect other signaling systems. The gene study did not directly establish a binding site on a receptor. It helped identify a biological route for later experiments to examine.

The most useful question to bring to an anxiety claim is what changed in the person's day. Someone may want to sleep through the night, join a conversation or finish a task they have been avoiding. Those goals make the outcome easier to define.

You can apply the same habit when reading a study. Identify the measured outcome first. Then look at the comparison group and the setting. In this experiment, exposure to stress changed the response to the same treatments. The researchers also needed movement measures to interpret the animals' exploration.

For a claim about human anxiety relief, look for a study that measures symptoms and daily function in the relevant people over time. Information about adverse effects matters alongside that benefit. If you discuss a treatment with a clinician, bring the complete study and explain the daily problem you want to improve.

Selank's maze study gives us a specific finding to work with: combined treatment changed exploration under prolonged stress, while the results for Selank alone and for animals outside that stress protocol followed different patterns. The molecular study offers a possible connection to the brain's inhibitory signaling. Each result helps define the next experiment.

What would less anxiety let you do more easily? Reply by email or leave a comment on the web article. That answer will help guide which outcomes I look for in future research.

Next is insulin, the peptide that changed diabetes treatment. New issues arrive Monday, Wednesday, and Friday.

1. Kasian A et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology, 2017:5091027. Open-access full text.

2. Volkova A et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 2016;7:31. Open-access full text.

For entertainment and education only. Not medical advice. Talk to your doctor before starting anything.